MEF2C and neoplasm: In addition, Luo et al. discovered that the expression of MEF2C-AS1 was markedly lower in the plasma of diffuse gastric cancer patients and the downregulation of MEF2C-AS1 facilitated invasive tumor behaviors in in-vitro experiments39.